BlackRock Investment Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
Other funds holding IART
BFA
CIP
BIT
BlackRock Investment Management's IART Position: Q4 2016 in Review
BlackRock Investment Management increased its Integra LifeSciences (IART) stake by 21% in Q4 2016, buying an estimated $2.2M and bringing the position to 306,232 shares worth $13.1M. The position accounts for 0.02% of the portfolio, ranked #933.
BlackRock Investment Management first reported a position in IART in Q2 2013 and has held it in 15 quarters since. 223 funds tracked by Wall St. Rank hold IART as of Q4 2016.
- BlackRock Investment Management held 306,232 shares of Integra LifeSciences worth $13.1M as of Q4 2016.
- BlackRock Investment Management bought 54,036 Integra LifeSciences shares in Q4 2016, an estimated $2.2M.
- Integra LifeSciences made up 0.02% of BlackRock Investment Management's portfolio in Q4 2016, its #933 holding.
- BlackRock Investment Management first reported a position in Integra LifeSciences in Q2 2013 and has held it in 15 quarters since.
- 223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2016.
Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.